Biomapas Receives CIR (French Research Tax Credit) Accreditation
August 27, 2018
Biomapas a annoncé récemment avoir reçu de la part du Ministère de l’enseignement supérieur et de la recherche l’accréditation Crédit d’Impôt Recherche (CIR) pour une période de trois ans.
Biomapas has recently announced that it has received Research Tax Credit (Crédit d’Impôt Recherche; CIR) accreditation for a three-year period from the French Ministry of Higher Education and Research.
Biomapas announces the opening of a new office in Sweden
August 16, 2018
Biomapas has recently announced the opening of a new office in Stockholm, Sweden. This new location strengthens Biomapas’ presence in the Nordic countries and further accommodates the rapid growth of the company.
The expansion into the Nordics is in direct response to demand from Biomapas clients seeking local Regulatory and Pharmacovigilance support. The company already has offices in Switzerland, Lithuania, Russia, Georgia and Ukraine. (more…)
Lithuania intends to take on the RMS role from UK for 70 Mutual Recognition and Decentralised Procedures
July 31, 2018
The United Kingdom (UK) submitted on 29 March 2017 the notification of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on European Union (EU). This means that the United Kingdom will become a ‘third country’ from 30 March 2019. According to Directive 2001/83/EC the reference member state (RMS) must be a member of the EU. As a result the RMS role in Mutual Recognition and Decentralised Procedures (MRP/DCP) must be transferred to an EU country. (more…)
Biomapas Appoints Chief Commercial Officer
July 15, 2018
Biomapas, a full service CRO with offices across central / eastern Europe and CIS countries, has been experiencing strong growth over the past few years. The company has recently appointed Chris Hamilton as Chief Commercial Officer.
Audrius Sveikata, CEO of Biomapas, said, “We are delighted to have Chris Hamilton join the company. He is a strategic appointment for Biomapas and will play an important role in managing our continued growth.” (more…)
Harmonization of EAEU GVP: CIS is getting more vigilant than ever before
March 23, 2018
On the 6-7 March, Biomapas Pharmacovigilance Department management and team from the CIS region participated in a meeting in Minsk. It was dedicated to strengthening collaboration between the team members as well as updating knowledge on latest PV trends. We discussed the most recent releases of legislation, such as Eurasian Economic Union Good Pharmacovigilance Practice harmonization and the importance of a teamwork approach with Biomapas’ PV Project Manager CIS, Aliaksandr Bakshtanovich, MD. (more…)
AICROS Annual Meeting: insights and future perspectives
February 28, 2018
The Association of International Clinical Research Organizations (AICROS) is a network of small to mid-size CROs, which provide clinical research services to the pharmaceutical, biotech and medtech industries. Biomapas joined AICROS in 2014 and since then has been an active member of the association. On the 20-22 February, Biomapas’ CEO Audrius Sveikata participated in the AICROS Annual meeting, which took place in Tel Aviv, Israel. Audrius shared his insights about the meeting and the future perspectives of the association. (more…)